Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Santini

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Expert Opinion on Pharmacotherapy|May 5, 2001
Amifostine: chemotherapeutic and radiotherapeutic protective effectsV Santini
Modern Problems of Pharmacopsychiatry|January 1, 1989
A general practice trial of Ateroid 200 in 8,776 patients with chronic senile cerebral insufficiencyV Santini
Bollettino Chimico Farmaceutico|May 1, 1974
[Analysis of the action of some substances on the visceral nerve endings]G Benelli, V Santini
Haematologica|December 20, 1999
The potential of amifostine: from cytoprotectant to therapeutic agentV Santini, F J Giles
British Journal of Haematology|September 30, 1998
Differentiation therapy of myelodysplastic syndromes: fact or fiction?V Santini, P R Ferrini
Pharmacology|January 1, 1972
Differences in microsomal enzyme induction between Sprague-Dawley and Long-Evans ratsA Jori, C Pugliatti, V Santini
Journal of Chemotherapy (Florence, Italy)|July 9, 2008
Treatment options in myelodysplastic syndromes: a new frontierV Santini, A Gozzini, A Bosi
Current Drug Metabolism|May 17, 2007
Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical applicationV Santini, A Gozzini, G Ferrari
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1975
Study of the action of some centrally acting drugs on the EEG and on a conditioned avoidance reflex in the rabbitM Bonfitto, D D Bella, V Santini
Biochemical Pharmacology|November 1, 1971
Daily rhythmic variation and liver drug metabolism in ratsA Jori, E Di Salle, V Santini
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Expert Opinion on Pharmacotherapy|May 5, 2001
Amifostine: chemotherapeutic and radiotherapeutic protective effectsV Santini
Modern Problems of Pharmacopsychiatry|January 1, 1989
A general practice trial of Ateroid 200 in 8,776 patients with chronic senile cerebral insufficiencyV Santini
Bollettino Chimico Farmaceutico|May 1, 1974
[Analysis of the action of some substances on the visceral nerve endings]G Benelli, V Santini
Haematologica|December 20, 1999
The potential of amifostine: from cytoprotectant to therapeutic agentV Santini, F J Giles
British Journal of Haematology|September 30, 1998
Differentiation therapy of myelodysplastic syndromes: fact or fiction?V Santini, P R Ferrini
Pharmacology|January 1, 1972
Differences in microsomal enzyme induction between Sprague-Dawley and Long-Evans ratsA Jori, C Pugliatti, V Santini
Journal of Chemotherapy (Florence, Italy)|July 9, 2008
Treatment options in myelodysplastic syndromes: a new frontierV Santini, A Gozzini, A Bosi
Current Drug Metabolism|May 17, 2007
Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical applicationV Santini, A Gozzini, G Ferrari
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1975
Study of the action of some centrally acting drugs on the EEG and on a conditioned avoidance reflex in the rabbitM Bonfitto, D D Bella, V Santini
Biochemical Pharmacology|November 1, 1971
Daily rhythmic variation and liver drug metabolism in ratsA Jori, E Di Salle, V Santini
Pageof 8